July 2016

Safety Related Changes

Skelid (tiludronate disodium) should not be used in juvenile Pagetic patients as safety and efficacy has not been established.

Valoid (cyclizine lactate) should not be given to patients who have acute myocardial infarction. Valoid should also not be given to patients who have acute alcohol intoxication. The anti‑emetic properties of cyclizine may increase the toxicity of alcohol.

Voltaren (diclofenac sodium) is now contraindicated in patients with severe hepatic impairment. Voltaren is now also contraindicated in the treatment of perioperative pain in setting of coronary artery bypass surgery (CABG).

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia┬áPty Ltd. All rights reserved.

MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629